These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada. Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702 [TBL] [Abstract][Full Text] [Related]
4. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children. Hallander HO; Ljungman M; Storsaeter J; Gustafsson L APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530 [TBL] [Abstract][Full Text] [Related]
5. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children. Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950 [TBL] [Abstract][Full Text] [Related]
7. Serotype specificity of vaccine-induced immunity to pertussis. Preston NW; Carter EJ Commun Dis Rep CDR Rev; 1992 Dec; 2(13):R155-6. PubMed ID: 1285135 [TBL] [Abstract][Full Text] [Related]
8. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Witt MA; Katz PH; Witt DJ Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Gustafsson L; Hessel L; Storsaeter J; Olin P Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988 [TBL] [Abstract][Full Text] [Related]
10. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. Knuf M; Schmitt HJ; Wolter J; Schuerman L; Jacquet JM; Kieninger D; Siegrist CA; Zepp F J Pediatr; 2008 May; 152(5):655-60, 660.e1. PubMed ID: 18410769 [TBL] [Abstract][Full Text] [Related]
11. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis. Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216 [TBL] [Abstract][Full Text] [Related]
12. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands. David S; Vermeer-de Bondt PE; van der Maas NA Vaccine; 2008 Oct; 26(46):5883-7. PubMed ID: 18775463 [TBL] [Abstract][Full Text] [Related]
13. [Acellular pertussis vaccine]. Wiedermann G; Ambrosch F; Vanura H Wien Med Wochenschr; 1991; 141(12):270-2. PubMed ID: 1949820 [TBL] [Abstract][Full Text] [Related]
14. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Witt MA; Arias L; Katz PH; Truong ET; Witt DJ Clin Infect Dis; 2013 May; 56(9):1248-54. PubMed ID: 23487373 [TBL] [Abstract][Full Text] [Related]
15. Case-control study of vaccination history in relation to pertussis risk during an outbreak among school students. Khan FN; Lin M; Hinkle CJ; Franklin P; Luther R; Woodruff F; Henson K; Lukenbill M; Gutierrez M; Zhu BP Pediatr Infect Dis J; 2006 Dec; 25(12):1132-6. PubMed ID: 17133158 [TBL] [Abstract][Full Text] [Related]
16. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination. Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499 [TBL] [Abstract][Full Text] [Related]
17. Pertussis before and after the introduction of acellular pertussis vaccines in Finland. Elomaa A; He Q; Minh NN; Mertsola J Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060 [TBL] [Abstract][Full Text] [Related]
18. Do we need a new vaccine to control the re-emergence of pertussis? Mills KH; Ross PJ; Allen AC; Wilk MM Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284 [TBL] [Abstract][Full Text] [Related]
19. Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccination. Olin P; Hallander HO; Gustafsson L; Barreto L; Podda A Dev Biol Stand; 1998; 95():211-20. PubMed ID: 9855434 [TBL] [Abstract][Full Text] [Related]
20. Economic impact of the introduction of an acellular pertussis vaccine in Canada: a 6-year analysis. Iskedjian M; De Serres G; Einarson TR; Walker JH Vaccine; 2010 Jan; 28(3):714-23. PubMed ID: 19895923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]